Your browser doesn't support javascript.
loading
Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples.
Alemany, L; Saunier, M; Tinoco, L; Quirós, B; Alvarado-Cabrero, I; Alejo, M; Joura, E A; Maldonado, P; Klaustermeier, J; Salmerón, J; Bergeron, C; Petry, K U; Guimerà, N; Clavero, O; Murillo, R; Clavel, C; Wain, V; Geraets, D T; Jach, R; Cross, P; Carrilho, C; Molina, C; Shin, H R; Mandys, V; Nowakowski, A M; Vidal, A; Lombardi, L; Kitchener, H; Sica, A R; Magaña-León, C; Pawlita, M; Quint, W; Bravo, I G; Muñoz, N; de Sanjosé, S; Bosch, F X.
Afiliación
  • Alemany L; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain. Electronic address: lalemany@iconcologia.net.
  • Saunier M; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Tinoco L; Hospital Oncológico, Quito, Ecuador.
  • Quirós B; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Alvarado-Cabrero I; Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.
  • Alejo M; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Hospital General de L'Hospitalet, Barcelona, Spain.
  • Joura EA; Department of Gynaecology and Obstetrics, Medical University of Vienna, Comprehensive Cancer Center, Vienna, Austria.
  • Maldonado P; Instituto de Ginecologia da Universidad Federal Do Rio de Janeiro-UFRJ, Rio de Janeiro, Brazil.
  • Klaustermeier J; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.
  • Salmerón J; Mexican Oncology Hospital, IMSS, Mexico, DF, Mexico.
  • Bergeron C; Laboratoire Cerba, Department de Pathologie, Paris, France.
  • Petry KU; Klinikum Wolfsburg, Wolfsburg, Germany.
  • Guimerà N; DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
  • Clavero O; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Murillo R; Instituto Nacional de Cancerología, Bogotá, Colombia.
  • Clavel C; CHU Reims, Hopital Maison Blanche, Laboratoire Pol Bouin, Reims, France; INSERM UMR-S903, Reims, France.
  • Wain V; WestMead Hospital, Sydney, Australia.
  • Geraets DT; DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
  • Jach R; Jagiellonian University Medical College, Krakow, Poland.
  • Cross P; Queen Elizabeth Hospital, Sheriff Hill, UK.
  • Carrilho C; Faculty of Medicine, Eduardo Mondlane University and Maputo Central Hospital, Maputo, Mozambique.
  • Molina C; Centro de Oncología Preventiva, Universidad de Chile, Santiago, Chile.
  • Shin HR; National Cancer Center, Seoul, South Korea.
  • Mandys V; Third Faculty of Medicine and Faculty Hospital King's Wineyards, Prague, Czech Republic.
  • Nowakowski AM; Medical University of Lublin, Lublin, Poland.
  • Vidal A; Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Lombardi L; Centro de Investigación Epidemiológica en Salud Sexual y Reproductiva - CIESAR, Hospital General San Juan de Dios - HGSJDD, Guatemala, Guatemala.
  • Kitchener H; Manchester Royal Infirmary, Manchester, United Kingdom.
  • Sica AR; Laboratorio de Anatomia Patológica del Hospital de la Mujer, Montevideo, Uruguay.
  • Magaña-León C; Instituto Potosino de Investigación Científica y Tecnológica, AC (IPICYT), San Luis Potosí, Mexico.
  • Pawlita M; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Quint W; DDL Diagnostic Laboratory, Rijswijk, The Netherlands.
  • Bravo IG; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Muñoz N; Cancer Institute of Colombia, Colombia.
  • de Sanjosé S; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Spain.
  • Bosch FX; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Eur J Cancer ; 50(16): 2846-54, 2014 Nov.
Article en En | MEDLINE | ID: mdl-25155250
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles Asunto principal: Papillomaviridae / Neoplasias Vaginales / Carcinoma de Células Escamosas / Infecciones por Papillomavirus Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Año: 2014 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_enfermedades_transmissibles Asunto principal: Papillomaviridae / Neoplasias Vaginales / Carcinoma de Células Escamosas / Infecciones por Papillomavirus Tipo de estudio: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Eur J Cancer Año: 2014 Tipo del documento: Article